<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Validation Dataset Example - Fetal movement counting for assessment of fetal wellbeing.</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: transparent;
            min-height: 100vh;
            padding: 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: transparent;
        }
        
        /* Review Header Section */
        .review-header {
            background: linear-gradient(135deg, #e8e8e8 0%, #f5f5f5 100%);
            color: #333;
            padding: 25px 30px;
            border-radius: 15px;
            margin-bottom: 25px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.1);
        }
        
        .review-title {
            font-size: 1.6em;
            font-weight: bold;
            margin-bottom: 20px;
            line-height: 1.3;
            display: flex;
            align-items: flex-start;
            gap: 12px;
        }
        
        .review-title-icon {
            font-size: 1.2em;
        }
        
        .review-meta {
            display: flex;
            gap: 15px;
            margin-bottom: 20px;
            flex-wrap: wrap;
        }
        
        .review-badge {
            background: rgba(0,0,0,0.1);
            padding: 5px 12px;
            border-radius: 20px;
            font-size: 0.8em;
            font-weight: 500;
        }
        
        .review-section {
            background: rgba(0,0,0,0.05);
            padding: 15px 18px;
            border-radius: 10px;
            margin-top: 15px;
            font-size: 0.9em;
            line-height: 1.6;
        }
        
        .review-section-title {
            font-weight: bold;
            color: #555;
            margin-bottom: 10px;
            font-size: 0.85em;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }
        
        /* Toggle Buttons */
        .toggle-container {
            display: flex;
            justify-content: center;
            margin-bottom: 25px;
            gap: 0;
        }
        
        .toggle-btn {
            padding: 12px 30px;
            font-size: 1em;
            font-weight: 600;
            border: none;
            cursor: pointer;
            transition: all 0.3s ease;
            background: rgba(200, 200, 200, 0.3);
            color: #555;
        }
        
        .toggle-btn:first-child {
            border-radius: 25px 0 0 25px;
        }
        
        .toggle-btn:last-child {
            border-radius: 0 25px 25px 0;
        }
        
        .toggle-btn.active.included {
            background: #28a745;
            color: white;
            box-shadow: 0 4px 15px rgba(40, 167, 69, 0.4);
        }
        
        .toggle-btn.active.excluded {
            background: #dc3545;
            color: white;
            box-shadow: 0 4px 15px rgba(220, 53, 69, 0.4);
        }
        
        .toggle-btn:hover:not(.active) {
            background: rgba(150, 150, 150, 0.3);
        }
        
        /* Papers Container */
        .papers-section {
            background: transparent;
        }
        
        .papers-grid {
            display: grid;
            gap: 20px;
        }
        
        .paper-card {
            background: rgba(255,255,255,0.98);
            border-radius: 12px;
            padding: 20px 25px;
            box-shadow: 0 3px 12px rgba(0,0,0,0.08);
            border-left: 6px solid;
            transition: transform 0.2s, box-shadow 0.2s, opacity 0.3s;
            position: relative;
        }
        
        .paper-card:hover {
            transform: translateX(8px);
            box-shadow: 0 6px 20px rgba(0,0,0,0.12);
        }
        
        .paper-card.included {
            border-left-color: #28a745;
        }
        
        .paper-card.excluded {
            border-left-color: #dc3545;
        }
        
        .paper-card.hidden {
            display: none;
        }
        
        .paper-number {
            position: absolute;
            top: -10px;
            left: -10px;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            font-size: 0.85em;
            color: white;
        }
        
        .paper-card.included .paper-number {
            background: #28a745;
        }
        
        .paper-card.excluded .paper-number {
            background: #dc3545;
        }
        
        .paper-title {
            font-weight: 600;
            font-size: 1.05em;
            color: #333;
            margin-bottom: 12px;
            line-height: 1.4;
            padding-right: 10px;
        }
        
        .paper-abstract {
            font-size: 0.88em;
            color: #555;
            line-height: 1.7;
            text-align: justify;
        }
        
        .paper-pmid {
            font-size: 0.75em;
            color: #888;
            margin-top: 12px;
            font-weight: 500;
        }
        
        /* Section Label */
        .section-label {
            text-align: center;
            margin-bottom: 20px;
        }
        
        .section-label span {
            display: inline-block;
            padding: 8px 20px;
            border-radius: 25px;
            font-size: 0.9em;
            font-weight: bold;
        }
        
        .section-label.included span {
            background: #d4edda;
            color: #155724;
        }
        
        .section-label.excluded span {
            background: #f8d7da;
            color: #721c24;
        }
        
        /* Footer */
        .footer {
            text-align: center;
            margin-top: 30px;
            padding: 15px;
            color: #888;
            font-size: 0.8em;
        }
    </style>
</head>
<body>
    <div class="container">
        <!-- Review Header -->
        <div class="review-header">
            <div class="review-title">
                <span class="review-title-icon">ðŸ“‹</span>
                <span>Fetal movement counting for assessment of fetal wellbeing.</span>
            </div>
            <div class="review-meta">
                <span class="review-badge">PMID: 26467769</span>
                <span class="review-badge">Cochrane Systematic Review</span>
            </div>
            <div class="review-section">
                <div class="review-section-title">Full Abstract</div>
                BACKGROUND: Fetal movement counting is a method by which a woman quantifies the movements she feels to assess the condition of her baby. The purpose is to try to reduce perinatal mortality by alerting caregivers when the baby might be compromised. This method may be used routinely, or only in women who are considered at increased risk of complications affecting the baby. Fetal movement counting may allow the clinician to make appropriate interventions in good time to improve outcomes. On the other hand, fetal movement counting may cause unnecessary anxiety to pregnant women, or elicit unnecessary interventions. OBJECTIVES: To assess outcomes of pregnancy where fetal movement counting was done routinely, selectively or was not done at all; and to compare different methods of fetal movement counting. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2015) and reference lists of retrieved studies. SELECTION CRITERIA: Randomised controlled trials (RCTs) and cluster-RCTs where fetal movement counting was assessed as a method of monitoring fetal wellbeing. DATA COLLECTION AND ANALYSIS: Two review authors assessed studies for eligibility, assessed the methodological quality of included studies and independently extracted data from studies. Where possible the effects of interventions were compared using risk ratios (RR), and presented with 95% confidence intervals (CI). For some outcomes, the quality of the evidence was assessed using the GRADE approach. MAIN RESULTS: Five studies (71,458 women) were included in this review; 68,654 in one cluster-RCT. None of these five trials were assessed as having low risk of bias on all seven risk of bias criteria. All included studies except for one (which included high-risk women as participants) included women with uncomplicated pregnancies.Two studies compared fetal movement counting with standard care, as defined by trial authors. Two included studies compared two types of fetal movement counting; once a day fetal movement counting (Cardiff count-to-10) with more than once a day fetal movement counting methods. One study compared fetal movement counting with hormone assessment.(1) Routine fetal movement counting versus mixed or undefined fetal movement countingNo study reported on the primary outcome 'perinatal death or severe morbidity'. In one large cluster-RCT, there was no difference in mean stillbirth rates per cluster (standard mean difference (SMD) 0.23, 95% CI -0.61 to 1.07; participants = 52 clusters; studies = one, low quality evidence). The other study reported no fetal deaths. There was no difference in caesarean section rate between groups (RR 0.93, 95% CI 0.60 to 1.44; participants = 1076; studies = one,low quality evidence). Maternal anxiety was significantly reduced with routine fetal movement counting (SMD -0.22, 95% CI -0.35 to -0.10; participants = 1013; studies = one, moderate quality evidence). Maternal-fetal attachment was not significantly different (SMD -0.02, 95% CI -0.15 to 0.11; participants = 951; studies = one, low quality evidence). In one study antenatal admission after reporting of decreased fetal movements was increased (RR 2.72, 95% CI 1.34 to 5.52; participants = 123; studies = one). In another there was a trend to more antenatal admissions per cluster in the counting group than in the control group (SMD 0.38, 95% CI -0.17 to 0.93; participants = 52 clusters; studies = one, low quality evidence). Birthweight less than 10th centile was not significantly different between groups (RR 0.98, 95% CI 0.66 to 1.44; participants = 1073; studies = one, low quality evidence). The evidence was of low quality due to imprecise results and because of concerns regarding unclear risk of bias. (2) Formal fetal movement counting (Modified Cardiff method) versus hormone analysisThere was no difference between the groups in the incidence of caesarean section (RR 1.18, 95% CI 0.83 to 1.69; participants = 1191; studies = one). Women in the formal fetal movement counting group had significantly fewer hospital visits than those randomised to hormone analysis (RR 0.26, 95% CI 0.20 to 0.35), whereas there were fewer Apgar scores less than seven at five minutes for women randomised to hormone analysis (RR 1.72, 95% CI 1.01 to 2.93). No other outcomes reported showed statistically significant differences. 'Perinatal death or severe morbidity' was not reported. (3) Formal fetal movement counting once a day (count-to-10) versus formal fetal movement counting method where counting was done more than once a day (after meals)The incidence of caesarean section did not differ between the groups under this comparison (RR 2.33, 95% CI 0.61 to 8.99; participants = 1400; studies = one). Perinatal death or severe morbidity was not reported. Women were more compliant in using the count-to-10 method than they were with other fetal movement counting methods, citing less interruption with daily activities as one of the reasons (non-compliance RR 0.25, 95% CI 0.19 to 0.32).Except for one cluster-RCT, included studies were small and used different comparisons, making it difficult to measure the outcomes using meta-analyses. The nature of the intervention measured also did not allow blinding of participants and clinicians.. AUTHORS' CONCLUSIONS: This review does not provide sufficient evidence to influence practice. In particular, no trials compared fetal movement counting with no fetal movement counting. Only two studies compared routine fetal movements with standard antenatal care, as defined by trial authors. Indirect evidence from a large cluster-RCT suggested that more babies at risk of death were identified in the routine fetal monitoring group, but this did not translate to reduced perinatal mortality. Robust research by means of studies comparing particularly routine fetal movement counting with selective fetal movement counting is needed urgently, as it is a common practice to introduce fetal movement counting only when there is already suspected fetal compromise.
            </div>
            <div class="review-section">
                <div class="review-section-title">Selection Criteria</div>
                SELECTION CRITERIA: Randomised controlled trials (RCTs) and cluster-RCTs where fetal movement counting was assessed as a method of monitoring fetal wellbeing.
            </div>
        </div>
        
        <!-- Toggle Buttons -->
        <div class="toggle-container">
            <button class="toggle-btn active included" onclick="showPapers('included')">
                âœ“ Included (5)
            </button>
            <button class="toggle-btn excluded" onclick="showPapers('excluded')">
                âœ— Excluded (5)
            </button>
        </div>
        
        <!-- Papers Section -->
        <div class="papers-section">
            <div class="section-label included" id="section-label-included">
                <span>Papers Cited in This Review (Passed Screening)</span>
            </div>
            <div class="section-label excluded" id="section-label-excluded" style="display:none;">
                <span>Papers from Related Reviews (Not Cited Here)</span>
            </div>
            
            <div class="papers-grid">
                
        <div class="paper-card included" data-label="included">
            <div class="paper-number">1</div>
            <div class="paper-title">The psychological effects of counting fetal movements.</div>
            <div class="paper-abstract">By identifying a change in fetal activity state, fetal movement counting may help to reduce the possibility of stillbirth. Concern has arisen that such a focus on fetal activity may cause undue maternal anxiety. A prospective, controlled trial was conducted to determine whether fetal movement counting induced anxiety or other deleterious psychological effects in low-risk primigravidas. A sample of 613 healthy pregnant women was randomly assigned at 28 weeks' gestation to fetal movement counting, sleep recording, or a nonrecording control group. State and trait of anxiety, belief in sources of personal control, and attitudes toward pregnancy and infant were assessed at 28 and 37 weeks' gestation. Participation rates were high (91.4%) across all groups. Most women (90%) assigned to count fetal movements did so on a daily basis (95% of days). No significant changes in psychological status occurred in the three groups as a result of self-monitoring conditions. Independent of group assignment, all women showed a slight increase in transient state and decrease in trait of anxiety from 28 to 37 weeks. Internal locus of control and positive attitudes toward the infant increased slightly, and feelings of well-being decreased slightly for all women. It was concluded that women are willing to record fetal activity, and that fetal movement counting does not cause deleterious psychological effects in low-risk pregnant women.</div>
            <div class="paper-pmid">PMID: 7857455</div>
        </div>
        
        <div class="paper-card included" data-label="included">
            <div class="paper-number">2</div>
            <div class="paper-title">Spontaneous motor activity in normal fetuses.</div>
            <div class="paper-abstract">AIM: The aim of this work was to perform a quantitative analysis of the different activities (mouth, eye and gross body movements) in the fetuses of 15 women with normally evolving pregnancies, and also to show the existence of intrauterine neurological maturation. METHODS: At 28, 34 and 38 weeks of gestation, 15 fetuses underwent a 60-min ultrasound observation. The data from the activities observed allowed the calculation, for each patient and each type of activity, of incidence, duration and intervals; relation between these and of each fetal activity for each gestational period; and the correlation between the different findings. RESULTS: The analysis of the data showed only a significant decrease in the incidence of gross body movements and a significant increase in the incidence of mouthing movements between 28 and 38 weeks of gestation. A correlation analysis failed to show any significant correlation between the various activities at 28 weeks, but found a positive correlation between eye, gross body movements and "other mouth movements," and a negative correlation between mouthing activity and the other activities examined at 34 and 38 weeks of gestation. CONCLUSION: The authors conclude that there is a trend of fetal activities, which is an expression of fetal neurological maturation.</div>
            <div class="paper-pmid">PMID: 11641034</div>
        </div>
        
        <div class="paper-card included" data-label="included">
            <div class="paper-number">3</div>
            <div class="paper-title">Fetal movement counting for assessment of fetal wellbeing.</div>
            <div class="paper-abstract">BACKGROUND: Fetal movement counting is a method by which a woman quantifies the movements she feels to assess the condition of the baby. The purpose is to try to reduce perinatal mortality by alerting caregivers when the baby might have become compromised. This method may be used routinely, or only in women who are considered at increased risk of complications in the baby. Some clinicians believe that fetal movement counting is a good method as it allows the clinician to make appropriate interventions in good time. On the other hand, fetal movement counting may cause anxiety to women. OBJECTIVES: To assess outcomes of pregnancy where fetal movement counting was done routinely, selectively or was not done at all; and to compare different methods of fetal movement counting. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2006), the Cochrane Central Register of Controlled Trials (The Cochrane Library) and the reference lists of relevant papers. SELECTION CRITERIA: Randomised controlled trials. Trials were excluded where allocation concealment was inadequate and no measures were taken to prevent bias were excluded. The interventions included routine fetal movement counting, selective fetal movement counting, and studies comparing different fetal assessment methods. DATA COLLECTION AND ANALYSIS: We assessed the methodological quality of included studies and extracted data from studies. MAIN RESULTS: Four studies, involving 71,370 women, were included in this review; 68,654 in one cluster-randomised trial. All four trials compared formal fetal movement counting. Two trials compared different types of counting with each other; one with no formal instruction, and one with hormonal analysis. Women in the formal fetal movement counting group had significantly fewer visits to the hospital antenatally than those women randomised to hormone analysis (relative risk (RR) 0.26, 95% confidence interval (CI) 0.20 to 0.35), whereas there were fewer Apgar scores less than seven in five minutes for women randomised to hormone analysis (RR 1.72, 95% CI 1.01 to 2.93). There was a significantly higher compliance with the Cardiff 'count to ten' method than with the formal fetal movement counting method (RR 0.25, 95% CI 0.19 to 0.32).All other outcomes reported were non significant. AUTHORS' CONCLUSIONS: This review does not provide enough evidence to influence practice. In particular, no trials compared fetal movement counting with no fetal movement counting. Robust research is needed in this area.</div>
            <div class="paper-pmid">PMID: 17253530</div>
        </div>
        
        <div class="paper-card included" data-label="included">
            <div class="paper-number">4</div>
            <div class="paper-title">Fetal movements in the third trimester--Important information about wellbeing of the fetus.</div>
            <div class="paper-abstract">It can be quite natural for pregnant women to believe that a decrease in the frequency of fetal movements at the end of pregnancy is normal if they have been so informed. There is also probably scope for interpretation concerning what is to be regarded as a decrease in the number of movements. Non-evidence-based information that a decrease in fetal movements is normal during the third trimester poses a threat to the unborn baby's life. If the mother does not react to a decrease in frequency and if she waits too long before contacting healthcare professionals, the window of opportunity to save the baby's life may be closed.</div>
            <div class="paper-pmid">PMID: 21122609</div>
        </div>
        
        <div class="paper-card included" data-label="included">
            <div class="paper-number">5</div>
            <div class="paper-title">Fetal movement counting--maternal concern and experiences: a multicenter, randomized, controlled trial.</div>
            <div class="paper-abstract">BACKGROUND: Fetal movement counting may improve timely identification of decreased fetal activity and thereby contribute to prevent adverse pregnancy outcomes, but it may also contribute to maternal concern. This study aimed to test whether fetal movement counting increased maternal concern. METHODS: In a multicenter, controlled trial 1,013 women with a singleton pregnancy were randomly assigned either to perform daily fetal movement counting from pregnancy week 28 or to follow standard Norwegian antenatal care where fetal movement counting is not encouraged. The primary outcome was maternal concern, measured by the Cambridge Worry Scale. Analysis was by intention-to-treat. RESULTS: The means and SDs on Cambridge Worry Scale scores were 0.77 (0.55) and 0.90 (0.62) for the intervention and the control groups, respectively, a mean difference between the groups of 0.14 (95% CI: 0.06-0.21, p<0.001). Decreased fetal activity was of concern to 433 women once or more during pregnancy, 45 and 42 percent in the intervention and control groups, respectively (relative risk=1.1, 95% CI: 0.9-1.2). Seventy-nine percent of the women responded favorably to the use of counting charts. CONCLUSIONS: Women who performed fetal movement counting in the third trimester reported less concern than those in the control group. The frequency of maternal report of concern about decreased fetal activity was similar between the groups. Most women considered the use of a counting chart to be positive.</div>
            <div class="paper-pmid">PMID: 22369601</div>
        </div>
        
                
        <div class="paper-card excluded" data-label="excluded">
            <div class="paper-number">1</div>
            <div class="paper-title">Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.</div>
            <div class="paper-abstract">BACKGROUND: There is evidence that certain antiepileptic drugs (AEDs) are teratogenic and are associated with an increased risk of congenital malformation. The majority of women with epilepsy continue taking AEDs throughout pregnancy; therefore it is important that comprehensive information on the potential risks associated with AED treatment is available. OBJECTIVES: To assess the effects of prenatal exposure to AEDs on the prevalence of congenital malformations in the child. SEARCH METHODS: We searched the Cochrane Epilepsy Group Specialized Register (September 2015), Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 11), MEDLINE (via Ovid) (1946 to September 2015), EMBASE (1974 to September 2015), Pharmline (1978 to September 2015), Reprotox (1983 to September 2015) and conference abstracts (2010-2015) without language restriction. SELECTION CRITERIA: We included prospective cohort controlled studies, cohort studies set within pregnancy registries and randomised controlled trials. Participants were women with epilepsy taking AEDs; the two control groups were women without epilepsy and women with epilepsy who were not taking AEDs during pregnancy. DATA COLLECTION AND ANALYSIS: Three authors independently selected studies for inclusion. Five authors completed data extraction and risk of bias assessments. The primary outcome was the presence of a major congenital malformation. Secondary outcomes included specific types of major congenital malformations. Where meta-analysis was not possible, we reviewed included studies narratively. MAIN RESULTS: We included 50 studies, with 31 contributing to meta-analysis. Study quality varied, and given the observational design, all were at high risk of certain biases. However, biases were balanced across the AEDs investigated and we believe that the results are not explained by these biases.Children exposed to carbamazepine (CBZ) were at a higher risk of malformation than children born to women without epilepsy (N = 1367 vs 2146, risk ratio (RR) 2.01, 95% confidence interval (CI) 1.20 to 3.36) and women with untreated epilepsy (N = 3058 vs 1287, RR 1.50, 95% CI 1.03 to 2.19). Children exposed to phenobarbital (PB) were at a higher risk of malformation than children born to women without epilepsy (N = 345 vs 1591, RR 2.84, 95% CI 1.57 to 5.13). Children exposed to phenytoin (PHT) were at an increased risk of malformation compared with children born to women without epilepsy (N = 477 vs 987, RR 2.38, 95% CI 1.12 to 5.03) and to women with untreated epilepsy (N = 640 vs 1256, RR 2.40, 95% CI 1.42 to 4.08). Children exposed to topiramate (TPM) were at an increased risk of malformation compared with children born to women without epilepsy (N = 359 vs 442, RR 3.69, 95% CI 1.36 to 10.07). The children exposed to valproate (VPA) were at a higher risk of malformation compared with children born to women without epilepsy (N = 467 vs 1936, RR 5.69, 95% CI 3.33 to 9.73) and to women with untreated epilepsy (N = 1923 vs 1259, RR 3.13, 95% CI 2.16 to 4.54). There was no increased risk for major malformation for lamotrigine (LTG). Gabapentin (GBP), levetiracetam (LEV), oxcarbazepine (OXC), primidone (PRM) or zonisamide (ZNS) were not associated with an increased risk, however, there were substantially fewer data for these medications.For AED comparisons, children exposed to VPA had the greatest risk of malformation (10.93%, 95% CI 8.91 to 13.13). Children exposed to VPA were at an increased risk of malformation compared with children exposed to CBZ (N = 2529 vs 4549, RR 2.44, 95% CI 2.00 to 2.94), GBP (N = 1814 vs 190, RR 6.21, 95% CI 1.91 to 20.23), LEV (N = 1814 vs 817, RR 5.82, 95% CI 3.13 to 10.81), LTG (N = 2021 vs 4164, RR 3.56, 95% CI 2.77 to 4.58), TPM (N = 1814 vs 473, RR 2.35, 95% CI 1.40 to 3.95), OXC (N = 676 vs 238, RR 3.71, 95% CI 1.65 to 8.33), PB (N = 1137 vs 626, RR 1.59, 95% CI 1.11 to 2.29, PHT (N = 2319 vs 1137, RR 2.00, 95% CI 1.48 to 2.71) or ZNS (N = 323 vs 90, RR 17.13, 95% CI 1.06 to 277.48). Children exposed to CBZ were at a higher risk of malformation than those exposed to LEV (N = 3051 vs 817, RR 1.84, 95% CI 1.03 to 3.29) and children exposed to LTG (N = 3385 vs 4164, RR 1.34, 95% CI 1.01 to 1.76). Children exposed to PB were at a higher risk of malformation compared with children exposed to GBP (N = 204 vs 159, RR 8.33, 95% CI 1.04 to 50.00), LEV (N = 204 vs 513, RR 2.33, 95% CI 1.04 to 5.00) or LTG (N = 282 vs 1959, RR 3.13, 95% CI 1.64 to 5.88). Children exposed to PHT had a higher risk of malformation than children exposed to LTG (N = 624 vs 4082, RR 1.89, 95% CI 1.19 to 2.94) or to LEV (N = 566 vs 817, RR 2.04, 95% CI 1.09 to 3.85); however, the comparison to LEV was not significant in the random-effects model. Children exposed to TPM were at a higher risk of malformation than children exposed to LEV (N = 473 vs 817, RR 2.00, 95% CI 1.03 to 3.85) or LTG (N = 473 vs 3975, RR 1.79, 95% CI 1.06 to 2.94). There were no other significant differences, or comparisons were limited to a single study.We found significantly higher rates of specific malformations associating PB exposure with cardiac malformations and VPA exposure with neural tube, cardiac, oro-facial/craniofacial, and skeletal and limb malformations in comparison to other AEDs. Dose of exposure mediated the risk of malformation following VPA exposure; a potential dose-response association for the other AEDs remained less clear. AUTHORS' CONCLUSIONS: Exposure in the womb to certain AEDs carried an increased risk of malformation in the foetus and may be associated with specific patterns of malformation. Based on current evidence, LEV and LTG exposure carried the lowest risk of overall malformation; however, data pertaining to specific malformations are lacking. Physicians should discuss both the risks and treatment efficacy with the patient prior to commencing treatment.</div>
            <div class="paper-pmid">PMID: 27819746</div>
        </div>
        
        <div class="paper-card excluded" data-label="excluded">
            <div class="paper-number">2</div>
            <div class="paper-title">Placental Insufficiency in Fetuses That Slow in Growth but Are Born Appropriate for Gestational Age: A Prospective Longitudinal Study.</div>
            <div class="paper-abstract">OBJECTIVES: To determine whether fetuses that slow in growth but are then born appropriate for gestational age (AGA, birthweight >10th centile) demonstrate ultrasound and clinical evidence of placental insufficiency. METHODS: Prospective longitudinal study of 48 pregnancies reaching term and a birthweight >10th centile. We estimated fetal weight by ultrasound at 28 and 36 weeks, and recorded birthweight to determine the relative change in customised weight across two timepoints: 28-36 weeks and 28 weeks-birth. The relative change in weight centiles were correlated with fetoplacental Doppler findings performed at 36 weeks. We also examined whether a decline in growth trajectory in fetuses born AGA was associated with operative deliveries performed for suspected intrapartum compromise. RESULTS: The middle cerebral artery pulsatility index (MCA-PI) showed a linear association with fetal growth trajectory. Lower MCA-PI readings (reflecting greater diversion of blood supply to the brain) were significantly associated with a decline in fetal growth, both between 28-36 weeks (p = 0.02), and 28 weeks-birth (p = 0.0002). The MCA-PI at 36 weeks was significantly higher among those with a relative weight centile fall <20%, compared to those with a moderate centile fall of 20-30% (mean MCA-PI 1.94 vs 1.61; p<0.05), or severe centile fall of >30% (mean MCA-PI 1.94 vs 1.56; p<0.01). Of 43 who labored, operative delivery for suspected intrapartum fetal compromise was required in 12 cases; 9/18 (50%) cases where growth slowed, and 3/25 (12%) where growth trajectory was maintained (p = 0.01). CONCLUSIONS: Slowing in growth across the third trimester among fetuses subsequently born AGA was associated with ultrasound and clinical features of placental insufficiency. Such fetuses may represent an under-recognised cohort at increased risk of stillbirth.</div>
            <div class="paper-pmid">PMID: 26730589</div>
        </div>
        
        <div class="paper-card excluded" data-label="excluded">
            <div class="paper-number">3</div>
            <div class="paper-title">Periodontal disease and pregnancy outcomes: time to move on?</div>
            <div class="paper-abstract">Maternal periodontal disease is a highly prevalent condition that has been studied extensively in relation to adverse pregnancy outcomes, including preterm delivery, preeclampsia, and low birth weight. Investigators speculate that hematogenous transport of bacteria and/or pro-inflammatory mediators from sites of periodontal infection into the placenta, fetal membranes, and amniotic cavity induces pathological processes that lead to these adverse outcomes. Preliminary observational studies supported this hypothesis, but more recent work by our group and others do not demonstrate an increased risk of adverse pregnancy outcomes among women with periodontal disease, and most randomized trials fail to demonstrate improved perinatal outcomes following treatment of periodontal disease in pregnancy.</div>
            <div class="paper-pmid">PMID: 21992584</div>
        </div>
        
        <div class="paper-card excluded" data-label="excluded">
            <div class="paper-number">4</div>
            <div class="paper-title">Antepartum evaluation of the fetus and fetal well being.</div>
            <div class="paper-abstract">Despite widespread use of many methods of antenatal testing, limited evidence exists to demonstrate effectiveness at improving perinatal outcomes. An exception is the use of Doppler ultrasound in monitoring high-risk pregnancies thought to be at risk of placental insufficiency. Otherwise, obstetricians should proceed with caution and approach the initiation of a testing protocol by obtaining an informed consent. When confronted with an abnormal test, clinicians should evaluate with a second antenatal test and consider administering betamethasone, performing amniocentesis to assess lung maturity, and/or repeating testing to minimize the chance of iatrogenic prematurity in case of a healthy fetus.</div>
            <div class="paper-pmid">PMID: 22828105</div>
        </div>
        
        <div class="paper-card excluded" data-label="excluded">
            <div class="paper-number">5</div>
            <div class="paper-title">The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions.</div>
            <div class="paper-abstract">OBJECTIVE: This paper describes the development and validation of the Health Education Impact Questionnaire (heiQ). The aim was to develop a user-friendly, relevant, and psychometrically sound instrument for the comprehensive evaluation of patient education programs, which can be applied across a broad range of chronic conditions. METHODS: Item development for the heiQ was guided by a Program Logic Model, Concept Mapping, interviews with stakeholders and psychometric analyses. Construction (N=591) and confirmatory (N=598) samples were drawn from consumers of patient education programs and hospital outpatients. The properties of the heiQ were investigated using item response theory and structural equation modeling. RESULTS: Over 90 candidate items were generated, with 42 items selected for inclusion in the final scale. Eight independent dimensions were derived: Positive and Active Engagement in Life (five items, Cronbach's alpha (alpha)=0.86); Health Directed Behavior (four items, alpha=0.80); Skill and Technique Acquisition (five items, alpha=0.81); Constructive Attitudes and Approaches (five items, alpha=0.81); Self-Monitoring and Insight (seven items, alpha=0.70); Health Service Navigation (five items, alpha=0.82); Social Integration and Support (five items, alpha=0.86); and Emotional Wellbeing (six items, alpha=0.89). CONCLUSION: The heiQ has high construct validity and is a reliable measure of a broad range of patient education program benefits. PRACTICE IMPLICATIONS: The heiQ will provide valuable information to clinicians, researchers, policymakers and other stakeholders about the value of patient education programs in chronic disease management.</div>
            <div class="paper-pmid">PMID: 17320338</div>
        </div>
        
            </div>
        </div>
        
        <div class="footer">
            LSE-UKHSA Systematic Review Screening Project | Validation Dataset Example
        </div>
    </div>
    
    <script>
        // Initialize - hide excluded papers
        document.addEventListener('DOMContentLoaded', function() {
            showPapers('included');
        });
        
        function showPapers(label) {
            // Update toggle buttons
            const buttons = document.querySelectorAll('.toggle-btn');
            buttons.forEach(btn => {
                btn.classList.remove('active');
                if (btn.textContent.toLowerCase().includes(label)) {
                    btn.classList.add('active');
                }
            });
            
            // Update section labels
            document.getElementById('section-label-included').style.display = label === 'included' ? 'block' : 'none';
            document.getElementById('section-label-excluded').style.display = label === 'excluded' ? 'block' : 'none';
            
            // Show/hide papers
            const papers = document.querySelectorAll('.paper-card');
            papers.forEach(paper => {
                if (paper.dataset.label === label) {
                    paper.classList.remove('hidden');
                } else {
                    paper.classList.add('hidden');
                }
            });
        }
    </script>
</body>
</html>
